About C4 Therapeutics:
C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes. For more information, please visit www.c4therapeutics.com.
Job Summary
In this role, you will support the Quality function at C4 Therapeutics, with a keen focus on GMP Quality Assurance. You will oversee the manufacturing and testing of clinical trial material, including quality control and other types of analytical testing, and support for the Quality System. Your work will be integral as we advance safe, effective medicines through the clinical trial process and onto potential commercialization.
Your Role
Chemistry, Manufacturing & Controls (CMC) Support & Quality Oversight of Manufacturing and Analytical Testing
Stability Program Support
Quality System Support
Your Background
Required:
Preferred:
The base pay range for this position at commencement of employment is expected to be between $213,698 and $236,192 annually; however, base pay offered may vary depending on multiple individualized factors, including job-related knowledge, skills, and experience.
C4 Therapeutics is an Equal Opportunity Employer.
C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes.
Take the next step in your career journey